Search
for
Sort by
Research 751–780 of 1000+
- Chemotherapy-Induced Alopecia in Ovarian Cancer: Incidence, Mechanisms, and Impact Across Treatment Regimens
- Antihelminthic Drugs
- Effects of COVID-19 and Its Vaccination on Bullous Pemphigoid
- Hair and nail involvement in lupus erythematosus
- Hypertrichosis induced by latanoprost
- Circumscribed Alopecia Areata Incognita and Response to Tofacitinib
- Emerging Topical and Systemic JAK Inhibitors in Dermatology
- Prophylaxis and Management of Skin Toxicities
- Review of systemic methotrexate therapy in pediatric dermatoses
- Mucocutaneous reactions to chemotherapy
- Dermatological adverse events with taxane chemotherapy
- Efficacy and safety of methotrexate in alopecia areata
- Chemotherapy-induced iatrogenic injury of skin: New drugs and new concepts
- Cholecalciferol-grafted hollow mesoporous silica nanoparticles for targeted and sustained caffeine delivery in alopecia therapy
- Cutaneous complications of chemotherapeutic agents
- Botanical drug preparations for alleviating hair loss in menopausal women: a global ethnopharmacological mini-review
- Novel treatment of alopecia areata with shooting-type candlelit-dissolving microneedle
- Continued year-on-year improvement in hair density with systemic minoxidil in women with female pattern hair loss: A case series
- Urticaria induced by laser epilation: A clinical and histopathological study with extended follow‐up in 36 patients
- Chemotherapy‐induced alopecia management: Clinical experience and practical advice
- Prevention and Treatment of Chemotherapy-Induced Alopecia
- METHOTREXATE FOR GENERALIZED PUSTULAR PSORIASIS IN A 2-YEAR-OLD CHILD
- Preliminary results of the use of scalp microneedling in different types of alopecia
- JAK inhibition decreases the autoimmune burden in Down syndrome
- Successful treatment of rare linear lichen planopilaris with Ixekizumab
- Diphencyprone Induced Vitiligo: A Case Report
- The pharmacology of methotrexate
- Successful treatment of corticosteroid-resistant ophiasis-type alopecia areata (AA) with platelet-rich plasma (PRP)
- Imiquimod for Cervical and Vaginal Intraepithelial Neoplasia
- Optimizing clinical monitoring and management guidelines for capivasertib in HR-positive/HER2-negative advanced breast cancer: expert opinion